The Lyla Nsouli Foundation for Children's Brain Cancer Research was set up after our beautiful daughter, Lyla, was diagnosed, on August 13, 2011, at the age of 2 years and 8 months with an inoperable, incurable form of brain cancer called Diffuse Intrinsic Pontine Glioma. She was given months to live.
This Foundation was set up to find a cure for Brain Cancer. Its first objective is to target the worst form of brain cancer-DIPG. After what has happened to our daughter we are compelled to do all we can to try and prevent this disease from destroying children's lives (and their families) so violently, and to try and improve the prognosis for these children and eventually find a cure.
Nadim M Nsouli founded Inspired in 2013 with the goal of creating a leading global group of premium schools. Starting with Inspired’s first acquisition of Reddam House, a leading group of schools in South Africa, Nadim rapidly expanded the group globally via a series of acquisitions and building greenfield schools while maintaining the focus on only having the best schools around the world as part of the group.
Simone Cheetham Nsouli completed an MSc from The London School of Economics and Political Science in Media and Communications in 1999 after earning a BA with Distinction from McGill University. She then worked in financial investor relations consulting for several years before beginning a career in fundraising and investor relations in the hedge fund industry.
A holder of two honours degrees from Georgetown University’s School of Foreign Service, Princess Ghida married Prince Talal of Jordan in 1991. The late King Hussein appointed her as his Press Secretary and asked her to establish the International Press Office of the Royal Hashemite Court.
Mr Fakhry co-founded Core Capital in 2004, a leading mid-market growth capital focused private equity house with over £100m in assets under management and investments in 13 companies across a range of sectors.
Head of the Neuro-oncology Section in the Division of Haematology/Oncology at The Hospital for Sick Children, Toronto.
Medical Director, Neuro-Oncology Program. Cincinnati Children's Principal Investigator, Collaborative Ependymoma Research Network.
Consultant Paediatric Oncologist at Great Ormond Street Hospital in London.
Associate Professor and Leader of the Pediatric Cancer Biology Program in the Pape' Family Pediatric Research Institute, Department of Pediatrics, Oregon Health & Science University.
Full Member in the Department of Parmaceutical Sciences at St. Jude Children's Research Hospital.